glp 1 gip agonist GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 Receptor Agonists Explained for
Description
Marx N, et al
Hirshberg B, Parker A, Edelberg H, Donovan M, Iqbal N
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
The next phase is not one drug
Source: GoodhealthRx The use of GLP-1 therapies for weight loss is inhibiting access to advanced diabetes care
